Page last updated: 2024-08-23

anipamil and Familial Combined Hyperlipidemia

anipamil has been researched along with Familial Combined Hyperlipidemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frandsen, H; Hansen, BF; Hansen, JF; Mortensen, A	1

Other Studies

1 other study(ies) available for anipamil and Familial Combined Hyperlipidemia

Article	Year
(-)-anipamil retards atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:3 Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Body Weight; Calcium Channel Blockers; Cholesterol; Disease Models, Animal; Eating; Hyperlipidemia, Familial Combined; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Propylamines; Rabbits; Stereoisomerism	1995

Article

Year

(-)-anipamil retards atherosclerosis in Watanabe heritable hyperlipidemic rabbits.

Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:3

Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Body Weight; Calcium Channel Blockers; Cholesterol; Disease Models, Animal; Eating; Hyperlipidemia, Familial Combined; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Propylamines; Rabbits; Stereoisomerism

1995